Goles, Nerie G.

HRN: 27 22 01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2025
CEFTAZIDIME 1GM (VIAL)
07/19/2025
08/01/2025
IV
1gm
Q8
Vap
Remove - Pending Acceptance
07/19/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/19/2025
07/25/2025
IV
750mg
Q72hours
Vap
Remove - Pending Acceptance
07/27/2025
CEFTAZIDIME 1GM (VIAL)
07/27/2025
08/03/2025
IV
1gm
Q8
VAP
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: